Skip to main content
  • AHA: Zetia May Cut CV Events in Japanese Seniors

    Results from EWTOPIA75 trial not enough to change practice, experts says

    CHICAGO -- Elderly Japanese patients with elevated LDL cholesterol, but no history of coronary artery disease, who took ezetimibe (Zetia) saw a reduced risk of atherosclerotic cardiovascular events, researchers reported here.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details